Tag

Fda

All articles tagged with #fda

HHS plans two new FDA deputy commissioners, one for AI-focused technology
technology31 minutes ago

HHS plans two new FDA deputy commissioners, one for AI-focused technology

Health and Human Services plans two new FDA deputy commissioners—one for technology/AI and one for drugs—reporting to FDA commissioner nominee Heidi Overton, with no final decisions yet; potential candidates include Jared Seehafer for tech and Kyle Diamantas for drugs. The move comes amid FDA scrutiny over drug approvals, food safety challenges, and expanding AI use, including the Elsa tool and a pending AI-regulation discussion.

Fromm Dog Food Recall Warns Pet Owners to Stop Feeding Over Metal Contamination Risk
health16 hours ago

Fromm Dog Food Recall Warns Pet Owners to Stop Feeding Over Metal Contamination Risk

Wisconsin-based Fromm Family Foods is recalling more than 5,000 cases of its wet canned dog food nationwide due to potential metal contamination, including Turkey Pâté Wet Dog Food and Diner Classics Milo's Meatloaf Pâté Wet. Consumers should stop feeding the product, return it to the retailer, and monitor for symptoms such as vomiting or stomach discomfort; no illnesses have been reported yet. The recall followed metal-contamination complaints and is being coordinated with FDA safety advisories.

Alfalfa Sprouts Outbreak Across 15 States Tied to Multiple Germs
health17 hours ago

Alfalfa Sprouts Outbreak Across 15 States Tied to Multiple Germs

US health officials report at least 55 food-poisoning cases across 15 states linked to alfalfa sprouts from Minnesota’s Everything Sprouts, with infections from Salmonella and several Shiga toxin–producing E. coli strains. Among 34 interviewed patients, 26 reported eating alfalfa sprouts, prompting a recall of certain lots; FDA warnings and ongoing investigations highlight previous safety concerns at the facility.

FDA hold stalls Regenxbio's RGX-121 refiling amid spine MRI findings
biotech19 hours ago

FDA hold stalls Regenxbio's RGX-121 refiling amid spine MRI findings

The FDA has placed a clinical hold on Regenxbio’s RGX-121 due to asymptomatic spine MRI findings, derailing plans to refile for approval in MPS II (Hunter syndrome). The hold follows a prior safety signal in RGX-111 and expanded monitoring that identified five patients with likely benign spinal nodules; researchers will continue imaging and use FDA feedback to determine next steps, while Regenxbio forges ahead with RGX-202 and surabgene lomparvovec. Regenxbio’s stock declined in premarket trading.

FDA upgrades blueberry recall to highest risk amid E. coli cases
health21 hours ago

FDA upgrades blueberry recall to highest risk amid E. coli cases

The FDA has elevated the recall of GreenWise frozen blueberries to the highest risk level after E. coli contamination was linked to at least 12 illnesses and 4 hospital visits across eight states (AL, FL, GA, KY, NC, SC, TN, VA). The affected products include GreenWise Organic Whole Blueberries (10-oz and 48-oz) and GreenWise Organic Whole Mixed Berries (10-oz and 48-oz) with specific UPCs and best-by dates through Feb 9, 2028. Consumers who purchased these should not eat them and should seek care if experiencing symptoms such as severe stomach cramps, watery or bloody diarrhea, or vomiting.

FDA Escalates Egg Recall to Class I Over Salmonella Alarms
health2 days ago

FDA Escalates Egg Recall to Class I Over Salmonella Alarms

The FDA upgraded a major egg recall to Class I, signaling a high risk of serious health consequences from salmonella. The recall covers more than 1.5 million dozen eggs distributed by Midwest Poultry Services to six states under brands like Kroger and Simple Truth. The action follows at least 98 illnesses reported in 17 states and 26 hospitalizations. Recalled eggs have best-by dates July 20–Aug 17 and can be identified by carton codes listed on the FDA site; consumers should check their eggs and report symptoms if exposed.

Nearly 40,000 eye drops recalled over sterility concerns
health3 days ago

Nearly 40,000 eye drops recalled over sterility concerns

The FDA-classified Class II recall covers 39,060 bottles of Clear Eyes Maximum Itchy Eye Relief eye drops (lot 2552A, exp. 2027-09-30) distributed by Medtech Products Inc. The 15ml bottles, sold at major retailers, are being pulled due to lack of assurance of sterility; consumers should stop using them and return for refunds, and seek care if any issues arise. This recall follows prior eye-drop safety issues, such as the EzriCare outbreak in 2023.

FDA flags frozen GreenWise berries as highest-risk recall amid E. coli concerns
health3 days ago

FDA flags frozen GreenWise berries as highest-risk recall amid E. coli concerns

The FDA upgraded the recall of GreenWise frozen organic blueberries and mixed berries to Class I high risk due to a reasonable probability of serious harm or death from potential E. coli contamination, a escalation after earlier store withdrawals; the berries were distributed to at least eight states, with an import alert and broader risk assessment that widened the recall beyond a typical alert.

Widespread U.S. food recalls touch berries, peppers, bars and ready-to-eat foods
health3 days ago

Widespread U.S. food recalls touch berries, peppers, bars and ready-to-eat foods

A broad wave of recalls spans jalapeño-linked salmonella and related guacamole/salsas, blueberries tied to an E. coli outbreak, raw beef from Argentina, a large egg recall for potential salmonella, Outshine fruit bars possibly containing glass, Walmart tomato-soup kits with possible listeria, vegan cheddar puffs, and other items, prompting consumers to discard affected products and check specific lot/best-by dates.

Nationwide recall of Clear Eyes eye drops due to sterility concerns, FDA says
health3 days ago

Nationwide recall of Clear Eyes eye drops due to sterility concerns, FDA says

Nearly 40,000 bottles of Clear Eyes Maximum Itchy Eye Relief eye drops distributed nationwide have been voluntarily recalled by Medtech Products (owned by Prestige Consumer Healthcare) after the FDA flagged a lack of assurance of sterility; 39,060 units are affected (Lot 2552A, D-0766-2026, exp. 9/30/2027); no injuries have been reported; recall began July 29, 2026 and is ongoing; products were sold over the counter at retailers such as CVS and Walmart.

2026 recalls surge triggers public health fatigue and safety doubts
science4 days ago

2026 recalls surge triggers public health fatigue and safety doubts

An uptick in food recalls this year—ranging from cyclospora-contaminated lettuce and salmonella in eggs to jalapeño peppers, berries, dog food, and eye drops—has left thousands ill and spotlighted 'recall fatigue' as a risk to public trust. Experts say recall activity this year appears elevated, though it’s not yet clear if total recalls will exceed 2025; the bigger deals, not volume, drive impact. Contributing factors include media amplification, seasonal outbreak spikes, and funding/staff cuts at FDA and CDC, plus surveillance shifts and delays to the Traceability Rule. The article argues the solution is stronger prevention and clearer communication, along with bolstering safety institutions rather than dialing back recalls.

politics5 days ago

Trump’s FDA pick faces uphill Senate ride over vaccines and leadership chops

Heidi Overton, a physician and Trump aide, is nominated to head the FDA. Her involvement in Trump’s vaccine policy and loyalty to the White House have sparked opposition from Senate Republicans like Bill Cassidy and abortion-rights and MAHA advocates, threatening her confirmation. Critics say she lacks regulatory leadership experience, while supporters note her interagency policy work. If Cassidy blocks a committee vote, her path to Senate approval becomes unlikely.

Trump taps Heidi Overton to lead FDA, pushing an America First health agenda
politics5 days ago

Trump taps Heidi Overton to lead FDA, pushing an America First health agenda

Trump nominated Dr. Heidi Overton, a physician-scientist and policy aide with the America First Policy Institute, to head the FDA, signaling a shift toward an America First approach to drugs and public health. Her Senate confirmation will face scrutiny over her managerial experience and vaccine policy stances after the previous FDA chief resigned.